ND-003 Tablets
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Shenzhen NewDEL Biotech, Co., Ltd
Overview
ND-003 Tablets is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
ND-003 Tablets clinical trials
Explore related
Medical disclaimer. This page summarizes research about ND-003 Tablets for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.